Merck & Co. Inc. (MRK) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Merck & Co. Inc. (MRK)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

99.64

-1.34 (-1.33%)

At close: Jan 14, 2025, 3:59 PM

99.84

0.21%

Pre-market Jan 15, 2025, 05:58 AM EST

undefined% (undefined)

Bid	99.75
Market Cap	252.04B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	4.87
PE Ratio (ttm)	20.46
Forward PE	n/a
Analyst	Buy

Ask	100
Volume	7,051,095
Avg. Volume (20D)	11,136,449
Open	101.26
Previous Close	100.98
Day's Range	99.02 - 101.49
52-Week Range	94.48 - 134.63
Beta	undefined

About MRK

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops...

[Show more]

Industry Drug Manufacturers - General

Sector Healthcare

IPO Date Jan 13, 1978

Employees 70,000

Stock Exchange NYSE

Ticker Symbol MRK

Website https://www.merck.com

Analyst Forecast

According to 14 analyst ratings, the average rating for MRK stock is "Buy." The 12-month stock price forecast is $121, which is an increase of 21.44% from the latest price.

Buy 57.14%

Hold 28.57%

Sell 7.14%

Stock Forecasts

Next Earnings Release

Merck & Co. Inc. is scheduled to release its earnings on Feb 4, 2025, before market opens.
Analysts project revenue of $15.49B, reflecting a 5.88% YoY growth and earnings per share of 1.8, making a 5900.00% increase YoY.

Why Price Moved

1 week ago · Source

+1.3%

Merck & Compnay and OPKO Health shares are trading... Unlock content with Pro Subscription

1 month ago · Source

+2.15%

Merck shares are trading higher after the company along with Ridgeback Biotherapeutics initiated Phase 3 of the MOVe-NOW trial to evaluate Lagevrio.

News

1 day ago · youtube.com

Merck CEO Robert Davis goes one-on-one with Jim Cramer

Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare Conference to talk recent acquisitions, growth in its vaccine segment, opportunities in China and more.

1 day ago · youtube.com

We've seen patients on transplant lists taken off of them after starting Winrevair, says Merck CEO

1 day ago · youtube.com

The Big 3: PEP, AVAV, MRK

Kenny Polcari turns to companies which experienced recent downtrends that he believes can see bullish breakouts. He notes PepsiCo (PEP) as a major dividend grower, AeroVironment (AVAV) as a beneficiar...

1 day ago · seekingalpha.com

Merck & Co. Inc. (MRK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Merck & Co. Inc. (NYSE:MRK ) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 7:30 PM ET Company Participants Robert Davis - Chairman and CEO Dean Li - Executive VP & President of Merck ...

2 days ago · seekingalpha.com

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 bil...

2 days ago · youtube.com

3 Dividend Stocks for January 2025

#Morningstar  #IncomeInvestors #DividendStocks These dividend payers are all trading in 4-star territory. 00:00 Introduction 01:10 Comcast CMCSA 01:14 Merck MRK 01:56 United Parcel Service UPS I'm Dav...

4 days ago · seekingalpha.com

3 Ideal Buys From 51 'Safer' Dividends In 100 January Barron's Sustainable Dogs

Calvert Research and Management's annual review identified the top 100 sustainable companies based on over 230 ESG performance indicators, including workplace diversity and greenhouse-gas emissions. E...

5 days ago · businesswire.com

Atropos Health Collaborates with Merck for Rapid Evidence Generation to Accelerate Innovation for Life-Saving Treatments

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a pioneer in translating real-world clinical data into real-world evidence (RWE) for decision-making, today announced it will collaborate with Merck...

1 week ago · investors.com

8 Stocks' Huge Profit Growth Is About To Knock Your Socks Off

Looking for some truly wowing profit growth from S&P 500 companies. A few are likely to knock your socks off.

1 week ago · 247wallst.com

Merck Just Paid Investors: How Much Did They Receive?

Merck & Co. Inc. (NYSE: MRK) is rewarding its shareholders once again with a quarterly dividend of $0.81 per share, payable on Wednesday, Jan.

1 week ago · businesswire.com

Merck's GARDASIL® Receives Expanded Approval for Males in China

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck's GARDASIL® Receives Expanded Approval for Males in China.

1 week ago · reuters.com

Merck says its HPV vaccine for men was approved by China's drug regulator

U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration.

1 week ago · https://thefly.com

Wuxi Biologics upgraded to Overweight from Neutral at JPMorgan

JPMorgan upgraded Wuxi Biologics to Overweight from Neutral with a price target of HK$20, up from HK$13, citing expected order growth and improved margins. Although the newsthat WuXi Bio sold its Irel...

1 week ago · zacks.com

Merck (MRK) Rises Higher Than Market: Key Facts

Merck (MRK) closed at $99.72 in the latest trading session, marking a +0.59% move from the prior day.

1 week ago · reuters.com

China's WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to Merck for about $500 million.

1 week ago · businesswire.com

Merck to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the 43rd Annual J.P. Morgan Healthcare Conference.

1 week ago · forbes.com

Big Blue Chip Dividends? Try These ‘Dogs' Up To 6.8%

The Dogs of the Dow 2025 pay big dividends—up to 6.8%! Collectively they yield three-times what the broader market pays.

1 week ago · seekingalpha.com

January Dow Dogs: 1 'Safer' Buy, And 5 With Promise

Verizon Communications is the only Dow Dog meeting the ideal of annual dividends from $1K invested, exceeding the single share price. Analysts forecast 11.36% to 31.73% net gains from the top ten Dow ...

1 week ago · zacks.com

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

2 weeks ago · 247wallst.com

2025's Five Highest Yielding Dogs of the Dow Could Explode Higher

The ‘Dogs of the Dow' is a well-known strategy first published in 1991 by Michael Higgins.

Load More News